Advertisement

Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl INF277K018A5

NAV / 1-Day Return
28.91 / 0.58%
Total Assets
11.0 Bil
Inception Date
Dec 28, 2015
Expense Ratio
2.190%
Fee Level
Load
Deferred
Category
India Fund Sector - Healthcare
Investment Style
Large Growth
Minimum Initial Investment
5,000
Status
Open
TTM Yield
0.00%
Turnover
28%



Holdings

Portfolio Holdings
# Long
# Short
Equity Holding
39 0
Bond Holding
0 0
Other Holding
2 0
Total Holding
41 0
Equity Holdings
39
Bond Holdings
0
Other Holdings
2
Total Holdings
41
% Assets in Top 10 Holdings
59
Reported Turnover %
28.44
As of 03 / 31 / 24
Women Directors %
25
Women Executives %
13
Holdings
% Portfolio Weight
First Bought
Market Value as of Feb 28, 2025
Cur Currency
Share Change %
1-Year Return
Forward P/E
Equity Star Rating
Economic Moat
ESG Risk Rating Assessment
Sector
11.61 Jan 31, 2016 1,281,451,000
INR Indian Rupee
6.59 Healthcare
7.23 Aug 31, 2018 797,801,000
INR Indian Rupee
-7.16 15.43 None Healthcare
7.10 Apr 30, 2020 784,200,000
INR Indian Rupee
5.12 Healthcare
6.25 Apr 30, 2020 689,675,000
INR Indian Rupee
-1.52 Healthcare
6.22 Nov 30, 2017 686,131,000
INR Indian Rupee
25.31 Healthcare
5.21 Sep 30, 2017 575,234,000
INR Indian Rupee
57.24 Healthcare
4.75 Oct 31, 2020 523,920,000
INR Indian Rupee
55.12 Healthcare
3.98 Dec 31, 2016 439,631,000
INR Indian Rupee
5.16 Healthcare
3.74 Dec 31, 2022 413,130,000
INR Indian Rupee
-9.94 Healthcare
3.31 Dec 31, 2022 365,472,000
INR Indian Rupee
47.24 Healthcare
Holdings as of Feb 28, 2025 | The top 41 largest holdings are available for display across Equity, Bond and Other.


© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top